Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Jul 15, 2025 | Upslope Capital Management | 8.9% | 3.4% | 8697.T, CHG.L, CME, DPLM.L, DSFIR.AS, EVR, FCN, HOLN.SW, HSY, MKTX, QQ.L, SAND.ST, SMIN.L, SPX.L, TDY | defense, Europe, Exchanges, Hedging, Industrial, Long/Short, value, volatility | The fund holds defense contractors including Chemring and Teledyne Technologies, with Chemring being a top contributor during the quarter. The manager notes accelerating sector tailwinds and describes the cyclical boom in defense markets. | EVR FCN SMIN.L EVR FCN SMIN LN |
View |
| 2024 Q4 | Jan 15, 2025 | Upslope Capital Management | -7.3% | 9.4% | 7011.T, 8697.T, ATR, AXON, BARN.SW, CHG.L, CME, CMPO, CRL, DPLM.L, DSFIR.AS, GRMN, HSY, KOG.OL, NVT, NWC.TO, QQ.L, TDY, VFC, WPK.TO | Cyclical, defense, Europe, healthcare, Long/Short, turnaround, value | Multiple defense holdings including QinetiQ, Chemring, and Mitsubishi Heavy Industries positioned to benefit from accelerating UK, European, and Japanese defense spending. QinetiQ particularly well-positioned for AUKUS customers and evolving battlefield requirements. | QQ.L VFC CRL |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Fund Letters | Upslope Capital Management | DSM-Firmenich AG | Materials | Specialty Chemicals | Bull | Euronext Amsterdam | consumer staples, Europe, Firmenich Integration, Fragrance, portfolio transformation, specialty chemicals, Specialty Ingredients, Switzerland, Taste Ingredients | View Pitch |
| Mar 16, 2026 | Substack | Toff Cap Monday Monitor | DSM-Firmenich | Chemicals | Specialty Chemicals | Bull | Euronext Amsterdam | ANH unit sale, bullish narrative, Catalyst, DSM-Firmenich, financial profile, growth strategy, Investor Day, market reaction, Pricing power, specialty chemicals | View Pitch |
| Feb 17, 2026 | Substack | Toff Cap Monday Monitor | DSM-Firmenich | Chemicals | Specialty Chemicals | Bull | Euronext Amsterdam | ANH unit sale, bullish catalyst, cyclical headwinds, DSM-Firmenich, financial profile, growth focus, higher margins, Investor Day, Pricing power | View Pitch |
| Jan 8, 2026 | Substack | Jam Invest | DSM-Firmenich | Flavors & Fragrances | Flavors & Fragrances | Bull | Euronext Amsterdam | Animal Nutrition sale, Bronte Capital, Business momentum, DSM-Firmenich, Flavors & Fragrances, high switching costs, Net debt-free, Oligopoly markets, Pricing power, share repurchases | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||